Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

June 30, 2007

Conditions
Pulmonary HypertensionChronic Obstructive Pulmonary Disease
Interventions
DRUG

PRX-08066

Trial Locations (19)

14221

Buffalo Cardiology and Pulmonary Associates, P.C., Williamsville

26505

Morgantown Pulmonary Clinical Research, Morgantown

28207

American Health Research, Charlotte

29303

South Carolina Pharmaceutical Research, Spartanburg

Spartanburg Medical Research, Spartanburg

30030

Atlanta Insitute for Medical Research, Decatur

32720

University Clinical Research-DeLand, LLC, DeLand

33321

Central Medical Group, PA, Tamarac

33603

Clinical Research of West Florida, Inc., Tampa

36207

Pinnacle Research Group, LLC, Anniston

53215

Heart Care Associates, LLC, Milwaukee

60153

Loyola University Medical Center Foster McGraw Hospital, Maywood

66606

Veritas Clinical Specialities, Topeka

77030

Baylor College of Medicine, Houston

83814

Pulmonary Consultants of North Idaho, Coeur d'Alene

85013

Arizona Pulmonary Specialists, Ltd., Phoenix

95817

University of California-Davis Medical Group, Sacramento

02111

Tufts New England Medical Center, Boston

02114

Massachusetts General Hospital, Pulmonary Critical Care Unit, Boston

Sponsors
All Listed Sponsors
lead

Epix Pharmaceuticals, Inc.

INDUSTRY